India announces Asia Cup 2025 squad
Digest more
1hon MSN
Asia Cup 2025: BCCI Shuts Down Question On India Vs Pakistan Clash To Suryakumar Yadav, Ajit Agarkar
This controversy regarding the Asia Cup 2025 India vs Pakistan match spilled into India's squad announcement for the tournament, which featured chief selector Ajit Agarkar and captain Suryakumar Yadav.
Stocks in Asia were flat and oil slid on Tuesday before a key meeting of central bankers and as traders evaluated promising diplomatic signals toward ending hostilities between Russia and Ukraine.
Grab's growth prospects, cash position, and limited Western competition justify its higher price-to-sales ratio. See why GRAB stock is a Buy.
Aakash Chopra suggests Shubman Gill's inclusion likely sidelines Sanju Samson for the Asia Cup, with selectors prioritizing batting slots. While Agark
With Shreyas Iyer's exclusion, the team management has sent a clear message that he is not in their scheme of things for the next year's T20 World Cup.
In a latest development, Pakistan and Oman have withdrawn from the upcoming edition of the Asia Cup Hockey 2025, scheduled to be held in Bihar's Rajgir. Hockey India president Dilip Kumar Tirkey on Tuesday confirmed Pakistan's withdrawl from the tournament,
The challenge in Asia is not a lack of cooperation, but a temptation to institutionalize cooperation faster than the region can support. It should be resisted. Ken Jimbo rightly underscores recent progress in networking U.
China’s RemeGen has sold certain Asia rights to its phase 3-stage eye disease drug to Japan’s Santen Pharmaceutical for 250 million Chinese yuan ($34.8 million) upfront. | China’s RemeGen has sold certain Asia rights to its phase 3-stage eye disease drug to Japan’s Santen Pharmaceutical for 250 million Chinese yuan ($34.